BRKR
NASDAQBruker Corporation
SectorIndustrialsIndustryBiotechnology: Laboratory Analytical Instruments
Price$56.53+1.58 (+2.87%)
01:30 PM07:45 PM
News · 26 weeks520%
2026-04-192026-10-11
Mix2990d
- Insider14(48%)
- Other8(28%)
- SEC Filings3(10%)
- Earnings2(7%)
- Analyst2(7%)
Latest news
25 items- ANALYSTBruker downgraded by Analyst with a new price targetAnalyst downgraded Bruker from Overweight to Neutral and set a new price target of $60.00
- PRUntargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform ResolutionCharité principal investigator Markus Ralser and colleagues discover and map 179,000 plasma proteoforms, revealing a vast molecular landscape for functional proteomics in biomedical research, drug discovery and biomarker discovery Bruker Corporation (NASDAQ:BRKR) announced a seminal bioRxiv preprint, describing a draft atlas of the human plasma proteome at isoform, or proteoform, resolution. The study was conducted by principal investigator Markus Ralser at Charité – Universitätsmedizin Berlin and collaborators. The preprint "A draft atlas of the human plasma proteome at isoform resolution" was posted on September 28, 2026 at https://doi.org/10.64898/2026.09.26.754256. This press release
- PRBruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology ResearchMultiDIA-PASEF significantly increases protein sequence coverage on timsUltra AIP ProteoScape connects PASEF discovery with rapid prm-PASEF target validation Spectronaut® AI transfer learning accelerates adaptation to new MS capabilities Guided PASEF EXciD enables high-throughput glycopeptide characterization Integrated HDX-MS workflows advance protein conformation and interaction studies timsOmni™ enables RNA and DNA top-down structural and native RNA analysis At the Human Proteome Organization World Congress 2026, Bruker Corporation (NASDAQ:BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage, targeted validation, mo
- PRBruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC BerkeleyNew high-field NMR instrumentation strengthens biomolecular and materials science research at the UC Berkeley Pines Magnetic Resonance Center Bruker Corporation (NASDAQ:BRKR) today announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to next-generation NMR technologies, including 800 MHz–class instrumentation. These capabilities strengthen research in chemistry, materials science, structural biology, and related fields across UC Berkeley and Lawrence Berkeley National Laboratory. This press release features multimedia. View the f
- INSIDEREXEC VP&PRES BRUKER NANO INC. Munch Mark exercised 2,000 shares at a strike of $22.19 and sold $105,740 worth of shares (2,000 units at $52.87) as part of a pre-agreed trading plan (SEC Form 4)4 - BRUKER CORP (0001109354) (Issuer)
- ANALYSTUBS initiated coverage on Bruker with a new price targetUBS initiated coverage of Bruker with a rating of Neutral and set a new price target of $65.00
- PRBruker Corporation to Present at Upcoming Investor ConferencesBruker Corporation (NASDAQ:BRKR) announced today that its senior leadership will present at the following conferences: Wells Fargo 21st Annual Healthcare Conference in Boston, MA Wednesday, September 9, 2026 at 8:00 a.m. Eastern Time Morgan Stanley 24th Annual Global Healthcare Conference in New York City Wednesday, September 16, 2026, at 10:45 a.m. Eastern Time Bank of America Global Healthcare Conference in London, UK Tuesday, September 22, 2026, at 6:45 a.m. Eastern Time Live audio webcasts of the presentations will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays of the presentations will be posted in the "Events & Present
- PRBEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement FusionRRP Preferred for High-Field Demonstration and First-of-a-Kind Power Plant OpportunitiesBruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (NASDAQ:BRKR), and Luvata Materials & Solutions, a Business Unit of Luvata Group (LUVATA) today announced a strategic collaboration to support the rapidly growing demand for superconducting materials and technologies required by next-generation magnetic confinement fusion power demonstration plant projects worldwide.The BEST-LUVATA collaboration aims to further strengthen and expand industrial readiness and availability of high-performance RRP superconductors to significantly upscale global manufacturing capacity, enhance supply
- INSIDERChief Accounting Officer Bures Thomas was granted 4,035 shares, increasing direct ownership by 126% to 7,233 units (SEC Form 4)4 - BRUKER CORP (0001109354) (Issuer)
- INSIDERPresident BMID Group Pusch Wolfgang sold $197,614 worth of shares (3,473 units at $56.90) and was granted 3,120 shares, decreasing direct ownership by 3% to 9,801 units (SEC Form 4)4 - BRUKER CORP (0001109354) (Issuer)
- INSIDEREXECUTIVE VICE PRESIDENT, CFO Herman Gerald N was granted 15,794 shares and covered exercise/tax liability with 2,724 shares, increasing direct ownership by 13% to 111,354 units (SEC Form 4) to cover taxes4 - BRUKER CORP (0001109354) (Issuer)
- INSIDEREXEC VP&PRES BRUKER NANO INC. Munch Mark exercised 2,000 shares at a strike of $22.19, sold $115,200 worth of shares (2,000 units at $57.60) as part of a pre-agreed trading plan, was granted 14,443 shares and covered exercise/tax liability with 2,984 shares, increasing direct ownership by 9% to 134,806 units (SEC Form 4) (for tax liability)4 - BRUKER CORP (0001109354) (Issuer)
- INSIDERPRESIDENT & CEO Laukien Frank H was granted 29,463 shares and covered exercise/tax liability with 4,760 shares, increasing direct ownership by 0.06% to 38,507,043 units (SEC Form 4) to cover withholding tax4 - BRUKER CORP (0001109354) (Issuer)
- INSIDERPRESIDENT CALID Srega Juergen was granted 16,898 shares, increasing direct ownership by 11% to 174,625 units (SEC Form 4)4 - BRUKER CORP (0001109354) (Issuer)
- INSIDERPRES. & CEO, BRUKER BEST Prause Burkhard was granted 3,303 shares, increasing direct ownership by 13% to 28,461 units (SEC Form 4)4 - BRUKER CORP (0001109354) (Issuer)
- INSIDEREXEC VP&PRES BRUKER NANO INC. Munch Mark covered exercise/tax liability with 1,619 shares, decreasing direct ownership by 1% to 123,347 units (SEC Form 4) to satisfy withholding obligation4 - BRUKER CORP (0001109354) (Issuer)
- INSIDERPRESIDENT & CEO Laukien Frank H covered exercise/tax liability with 4,838 shares, decreasing direct ownership by 0.01% to 38,482,340 units (SEC Form 4) (tax withholding)4 - BRUKER CORP (0001109354) (Issuer)
- INSIDEREXECUTIVE VICE PRESIDENT, CFO Herman Gerald N covered exercise/tax liability with 1,410 shares, decreasing direct ownership by 1% to 98,284 units (SEC Form 4) (for tax liability)4 - BRUKER CORP (0001109354) (Issuer)
- INSIDERPRESIDENT & CEO Laukien Frank H covered exercise/tax liability with 6,925 shares, decreasing direct ownership by 0.02% to 38,487,178 units (SEC Form 4) (withholding tax)4 - BRUKER CORP (0001109354) (Issuer)
- INSIDEREXEC VP&PRES BRUKER NANO INC. Munch Mark covered exercise/tax liability with 3,477 shares, decreasing direct ownership by 3% to 124,966 units (SEC Form 4) to satisfy withholding obligation4 - BRUKER CORP (0001109354) (Issuer)
- INSIDEREXECUTIVE VICE PRESIDENT, CFO Herman Gerald N covered exercise/tax liability with 2,889 shares, decreasing direct ownership by 3% to 99,694 units (SEC Form 4) to satisfy withholding obligation4 - BRUKER CORP (0001109354) (Issuer)
- PRBruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving LaboratoriesEnables deeper integration of Atinary's SDLabs platform with Chemspeed automation, Bruker instruments and SciY software for closed-loop agentic AI-driven R&D Bruker Corporation (NASDAQ:BRKR) today announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs® technologies and AI-driven R&D with applications in pharmaceuticals, chemicals, energy, and materials. Bruker also made a minority investment in Atinary. Financial details were not disclosed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260811179936/en/Atinary Self-Driving Lab integrating Chemspeed robotics, a Fourier 80
- PRBruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and DevelopmentMIMETAS’ unique organ-on-a-chip and human tissue models complement Bruker’s multiomics, NMR, spatial biology and preclinical imaging solutions Bruker Corporation (NASDAQ:BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. The investment expands Bruker’s post-genomic solutions for disease biology research, as well as for drug discovery and development into Microphysiological Systems (MPS), also referred to as New Approach Methodologies (NAMs), and based on human physiology-relevant model systems. This press release features multimedia. View the full release he
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Bruker CorporationSCHEDULE 13G/A - BRUKER CORP (0001109354) (Subject)
- SECSEC Form 10-Q filed by Bruker Corporation10-Q - BRUKER CORP (0001109354) (Filer)
BRKR FAQ
7 questionsWhat does Bruker Corporation do?
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy...Where does BRKR stock trade?
Bruker Corporation (BRKR) is listed on NASDAQ.What sector and industry is BRKR in?
Bruker Corporation operates in the Industrials sector, Biotechnology: Laboratory Analytical Instruments industry.Does BRKR pay a dividend?
BRKR's most recent ex-dividend date was 2026-09-21 with a cash dividend of $0.05 per share. No future ex-date is on file yet.What are analysts saying about BRKR?
Bruker Corporation has had 8 recent analyst actions on file. The most recent action was from Analyst: Neutral on 2026-10-14. Recent price targets cluster around $4000.00.What companies are similar to BRKR?
Notable peers in the same industry include A (Agilent Technologies Inc.), WAT (Waters Corporation), MTD (Mettler-Toledo International Inc.), PKI (PerkinElmer Inc.), RVTY (Revvity Inc.). Compare BRKR side-by-side with any of them on Quantisnow.How can I track BRKR on Quantisnow?
Quantisnow aggregates Bruker Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BRKR to receive live email and push alerts on every new disclosure.